Literature DB >> 20347305

Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.

Souichi Nakashima1, Hisashi Matsuda, Ai Kurume, Yoshimi Oda, Seikou Nakamura, Masayuki Yamashita, Masayuki Yoshikawa.   

Abstract

Cucurbitane-type triterpenes, cucurbitacins B and E, were reported to exhibit cytotoxic effects in several cell lines mediated by JAK/STAT3 signaling. However, neither compound inhibited phosphorylation of STAT3 in human leukemia (U937) cells at low concentrations. We therefore synthesized a biotin-linked cucurbitacin E to isolate target proteins based on affinity for the molecule. As a result, cofilin, which regulates the depolymerization of actin, was isolated and suggested to be a target. Cucurbitacins E and I inhibited the phosphorylation of cofilin in a concentration-dependent manner, and their effective concentrations having the same range as the concentrations at which they had cytotoxic effects in U937 cells. In addition, the fibrous-/globular-actin ratio was decreased after treatment with cucurbitacin E in HT1080 cells. These findings suggested that the inhibition of cofilin's phosphorylation increased the severing activity of cofilin, and then the depolymerization of actin was enhanced after treatment with cucurbitacin E at lower concentrations. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347305     DOI: 10.1016/j.bmcl.2010.02.062

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

Review 1.  Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

Authors:  April L Risinger; Lin Du
Journal:  Nat Prod Rep       Date:  2019-11-25       Impact factor: 13.423

2.  Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42-Rac1-RhoA signaling protein levels.

Authors:  Weicheng Wang; Souichi Nakashima; Seikou Nakamura; Yoshimi Oda; Hisashi Matsuda
Journal:  J Nat Med       Date:  2019-01-09       Impact factor: 2.343

3.  Cucurbitacin I inhibits STAT3, but enhances STAT1 signaling in human cancer cells in vitro through disrupting actin filaments.

Authors:  Hui Guo; Shan Kuang; Qiao-Ling Song; Man Liu; Xiao-Xiao Sun; Qiang Yu
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

4.  Cucurbitacin E induces apoptosis of human prostate cancer cells via cofilin-1 and mTORC1.

Authors:  Xiaolong He; Qi Gao; Yayong Qiang; Wei Guo; Yadong Ma
Journal:  Oncol Lett       Date:  2017-04-24       Impact factor: 2.967

Review 5.  Targeting the cytoskeleton against metastatic dissemination.

Authors:  Carmen Ruggiero; Enzo Lalli
Journal:  Cancer Metastasis Rev       Date:  2021-01-20       Impact factor: 9.264

6.  Cell-modified plasmonic interface for the signal-amplified detection of Cucurbitacin E.

Authors:  Yaofei Chen; Shuihua Peng; Peili Zhao; Lei Chen; Gui-Shi Liu; Dongyun Ouyang; Yunhan Luo; Zhe Chen
Journal:  Biomed Opt Express       Date:  2021-12-10       Impact factor: 3.732

7.  Three-dimensional structural analysis reveals a Cdk5-mediated kinase cascade regulating hepatic biliary network branching in zebrafish.

Authors:  Manali Dimri; Cassandra Bilogan; Lain X Pierce; Gregory Naegele; Amit Vasanji; Isabel Gibson; Allyson McClendon; Kevin Tae; Takuya F Sakaguchi
Journal:  Development       Date:  2017-07-15       Impact factor: 6.868

8.  Cucurbitacin E exhibits anti-inflammatory effect in RAW 264.7 cells via suppression of NF-κB nuclear translocation.

Authors:  Jing Qiao; Li-hui Xu; Jian He; Dong-yun Ouyang; Xian-hui He
Journal:  Inflamm Res       Date:  2013-01-30       Impact factor: 4.575

9.  Cucurbitacin I inhibits cell motility by indirectly interfering with actin dynamics.

Authors:  David A Knecht; Rebecca A LaFleur; Alem W Kahsai; Christian E Argueta; Anwar B Beshir; Gabriel Fenteany
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

10.  The effects of methanolic, chloroform, and ethylacetate extracts of the Cucurbita pepo L. on the delay type hypersensitivity and antibody production.

Authors:  A Jafarian; B Zolfaghari; M Parnianifard
Journal:  Res Pharm Sci       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.